Fisher Asset Management’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Fisher Asset Management's AVTX Position: Q3 2026 in Review
Fisher Asset Management opened a new position in Avalo Therapeutics (AVTX) in Q3 2026: 316,505 shares worth $4.85M. The stake represents ﹤0.01% of the portfolio and ranks #475 among its holdings.
148 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Fisher Asset Management held 316,505 shares of Avalo Therapeutics worth $4.85M as of Q3 2026.
- Avalo Therapeutics was a new Fisher Asset Management position in Q3 2026.
- Avalo Therapeutics made up ﹤0.01% of Fisher Asset Management's portfolio in Q3 2026, its #475 holding.
- 148 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.